SAB Biotherapeutics Inc. (SABS) Stock Price, Quote & News

SAB Biotherapeutics Inc. (SABS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

4.08

1.24%

After-hours Dec 13, 2024, 04:00 PM EST

undefined% (undefined)

Bid	3.47
Market Cap	37.19M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-6.3
PE Ratio (ttm)	-0.64
Forward PE	n/a
Shares Out	9.23M
Short % of Shares Out	undefined%

Ask	4.05
Volume	30,188
Open	3.85
Previous Close	3.87
Day's Range	3.70 - 4.03
52-Week Range	2.16 - 7.99
Beta	undefined
Shares Float	-
Short % of Float	undefined%

About SABS

undefined

[Show more]

Industry -

Sector -

IPO Date n/a

Employees NaN

Stock Exchange -

Ticker Symbol SABS

Website -

Analyst Forecast

According to 0 analyst ratings, the average rating for SABS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Buy 0%

Hold 0%

Sell 0%

Stock Forecasts

Why Price Moved

News

No News article available yet